Stefan Arver, MD, PhD

Andrology Centre, Karolinska University Hospital, Stockholm, Sweden

An endocrine approach to address the cluster of risk factors associated with development of type II diabetes in men

Antonio Aversa, MD, PhD

Senior Researcher, Department of Medical Pathophysiology, Faculty of Medicine and Surgery, Professor of Sexual Medicine - 1st School of Endocrinology Specialization, University of Rome, Italy

Androgen deficiency and hormone replacement therapy

Hermann Behre, MD

Andrology Unit, Martin Luther University, Halle, Germany

How to select the right patient?

Kevin S. Channer, MD

Sheffield Hallam University and Royal Hallamshire Hospital, Sheffield, United Kingdom

Is there a link between obesity, diabetes, erectile dysfunction and cardiovascular disease?

Giovanni Corona, MD

Andrology Unit, University of Florence, Florence, Italy

Metabolic syndrome and sexual dysfunction

Andrea Fabbri, MD, PhD

Associate Professor of Endocrinology, Chair of Endocrinology, Dept. of Internal Medicine, University Tor Vergata, Rome, Italy

Pathogenesis of the metabolic syndrome: the interplay between obesity and androgens

André T. Guay, MD, FACP, FACE

Clinical Assistant Professor of Medicine (Endocrinology), Harvard Medical School, Boston, MA, USA
Director, Center For Sexual Function, Lahey Clinic Northshore, Peabody, MA, USA

His mind, his body, his spirit, his testosterone therapy & his erectile physiology

T. Hugh Jones, MD, MB, ChB, BSc, MRCP, FRCP

Centre for Diabetes and Endocrinology, Barnsley District General Hospital, UK
Academic Unit of Endocrinology, Division of Genomic Medicine, University of Sheffield Medical School, UK

Is there a role for testosterone in type II diabetes mellitus?

Frank-Michael Köhn, MD

Department of Dermatology and Allergy, Technichal University Munich, Munich, Germany

Testosterone and his body functions

Mario Maggi, MD

Full Professor of Endocrinology, Unità di Andrologia, Dipartimento di Fisiopatologia Clinica, Florence, Italy

Which patients with sexual dysfunction are suitable for testosterone replacement therapy?

Ignacio Moncada, MD

Hospital Gregorio Marañón, Madrid, Spain

Testosterone and his quality of life

Alvaro Morales, MD, FRCSC, FACS

Department of Urology, Kingston General Hospital, Queens University, Kingston, Ontario, Canada

Monitoring the safety and efficacy of intramuscular testosterone undecanoate in elderly hypogonadal men

Abraham Morgentaler, MD, FACS

Director, Men's Health Boston, Associate Clinical Professor of Urology, Harvard Medical School

TRT - Who is benefiting and who is at risk?

Eberhardt Nieschlag, MD

University of Münster, Germany

Choosing the right patient for testosterone replacement therapy: Introduction

Clinical experience with a new long-acting injectable testosterone undecanoate: Introduction

Markus Schubert, MD

University of Cologne, Köln, Germany

Comparison of kinetics, efficacy and safety of the long-acting testosterone undecanoate formulation with standard testosterone enanthate

Claude Schulman, MD, PhD

Cliniques Universitaires de Bruxelles, Universite Libre de Bruxelles, Hopital Erasme, Brussels, Belgium

His mind, his body, his spirit, his testosterone therapy: Introduction

His mind, his body, his spirit, his testosterone therapy: Summary

Ridwan Shabsigh, MD

Associate Professor of Urology, Columbia University, Director, New York Center of Human Sexuality, Department of Urology, Columbia-Presbyterian Medical Center, New York, NY, USA

Sexual health is the portal to men's health

Johan Svartberg, MD, PhD

Department of Medicine, University Hospital of North-Norway, Tromsø, Norway

Epidemiology - Testosterone and the metabolic syndrome

Abdulmaged M. Traish, PhD

Professor of Biochemistry and Urology, Boston University School of Medicine, Boston, MA, USA

Regulation of penile erection by androgen-dependent cellular and molecular mechanism

Aksam A. Yassin, MD, PhD

Consultant Urologist – Professor of Urology & Human Sexuality, Hamburg, Germany

Long-acting testosterone ester injection as a second line therapy in hypogonadal patients with erectile dysfunction

Michael Zitzmann, MD, PhD

Institute of Reproductive Medicine, Universitätsklinikum Münster, Münster, Germany

Testosterone and his brain

Long term experience of more than 8 years with a novel formulation of testosterone undecanoate (Nebido®) in substitution therapy of hypogonadal men